INNOVATION ARTICLES
-
Rethinking Tau Biology: The Future Of Neurodegenerative Drug Discovery
We caught up with Melissa Murray, Ph.D., and Amy Rommel, Ph.D., to discuss tau-associated neurodegenerative diseases.
-
MicroRNA Therapeutics In Metabolic Liver Disease: Context-Driven Drug Discovery
Realizing the therapeutic potential of miRNAs in liver disease requires confronting a problem the field has not fully reckoned with.
-
Viral Coinfections: Emerging Challenges In Modern Drug Discovery
Viral coinfection is a phenomenon more complex than just the concurrency or sequential infection with multiple viruses in the same host.
-
Hope For Non-Hallucinogenic Neuroplastogens
We caught up with Joseph Tucker, Ph.D., to discuss Enveric Bioscience’s focus on developing non-hallucinogenic neuroplastogenic compounds.
-
Video Spotlight: Harvard's Alice Stanton On Engineering Integrated Human-Derived miBrain Organoid Models
Alice Stanton, PhD, member of the faculty, Harvard Medical School, engineered the first 3D immuno-glial-neurovascular human multicellular integrated brain (miBrain) model. In this video spotlight interview, Dr. Stanton shares her journey into science and neural organoid research.
-
The Matchmaker Modality: Engineering Event-Driven Pharmacology With Induced Proximity
Induced proximity has evolved into a versatile platform with the potential to change drug discovery, but challenges still remain.
INNOVATION ARTICLES. APP NOTES, CASE STUDIES. & WHITE PAPERS
-
Overcome the complex ADME and DDI challenges of antibody–drug conjugates with tailored, data-driven strategies that accelerate development and support regulatory success.
-
Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.
-
High‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.
-
Structure‑enabled drug discovery revealed a novel, druggable binding site in Artemis, enabling rapid SAR optimization and a ~500‑fold potency improvement against a challenging oncology target.
-
Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
APAC is rapidly advancing its role in the global therapeutics landscape, fueled by faster development models. Learn how this momentum is reshaping expectations for innovation and commercialization.
INNOVATION SOLUTIONS
-
Achieve efficient, automated filtration for biopharmaceutical production with a system offering high throughput that is designed for ultrafiltration, diafiltration, and microfiltration.
-
Generate human-relevant data with an Organ-Chip system that combines automation, imaging, and cost efficiency for faster, more confident insights for drug development and complex biological studies.
-
With 12 independent Emulations in one consumable, Chip-Array optimizes workflows and reduces cell requirements—delivering scalable, physiologically relevant models for advanced research.
-
From cancer models to high-throughput screening, Organ-Chip platforms accelerate development, improve safety, and support regulatory compliance for next-generation therapies.
-
This advanced imaging approach uses spatial and morphological data for more detailed analysis, enabling breakthroughs in understanding cell growth, function, and interaction without usual limitations.
-
Achieve top spectral resolution with advanced optical design, quality control, and workflows. Simplify experiments while meeting your panel and fluorochrome needs for high-dimensional flow cytometry.
-
Achieve deeper T-cell characterization with a panel designed for flexibility. Streamline multicolor panel design, see higher resolution markers, and enable intracellular cytokine detection together.